Metabolic Pathways and Activity-Dependent Modulation of Glutamate Concentration in the Human Brain
Glutamate is one of the most versatile molecules present in the human brain, involved in protein synthesis, energy production, ammonia detoxification, and transport of reducing equivalents. Aside from these critical metabolic roles, glutamate plays a major part in brain function, being not only the most abundant excitatory neurotransmitter, but also the precursor for γ-aminobutyric acid, the predominant inhibitory neurotransmitter. Regulation of glutamate levels is pivotal for normal brain function, as abnormal extracellular concentration of glutamate can lead to impaired neurotransmission, neurodegeneration and even neuronal death. Understanding how the neuron-astrocyte functional and metabolic interactions modulate glutamate concentration during different activation status and under physiological and pathological conditions is a challenging task, and can only be tentatively estimated from current literature. In this paper, we focus on describing the various metabolic pathways which potentially affect glutamate concentration in the brain, and emphasize which ones are likely to produce the variations in glutamate concentration observed during enhanced neuronal activity in human studies.
KeywordsAspartate Glutamate Human brain Homeostasis In vivo studies Malate-aspartate shuttle Neuron-astrocyte interactions Neurotransmission Neuronal stimulation
Branched-chain keto acid dehydrogenase complex
Cytosolic aspartate amino-transferase
Cytosolic malic enzyme
Excitatory amino acids transporter
Mitochondrial aspartate amino-transferase
Mitochondrial malic enzyme
S. M. thanks the grant NIH R01 DK62440 for support. This project was also supported by the National Center for Research Resources (Grant Number P41 RR008079) and the National Institute of Biomedical Imaging and Bioengineering (Grant Number P41 EB015894) of NIH. Additional funding supports to CMRR are: Minnesota Medical Foundation, and P30 NS057091. This work was finally supported by the NIH grant 1UL1RR033183 and KL2 RR033182 from the National Center for Research Resources (NCRR) to the University of Minnesota Clinical and Translational Science Institute (CTSI).
- 4.Nilsson GE (1993) Neurotransmitters and anoxia resistance-comparative physiological and evolutionary perspectives. In: Hochachka PW, Lutz PL, Sick T, Rosenthal M, Van der Thillart G (eds) Surviving hypoxia: mechanisms of control and adaptation. CRC Press, Boca Raton, pp 401–413Google Scholar
- 5.Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 226(10):2484–2493. doi: 10.1002/jcp.22609 PubMedCrossRefGoogle Scholar
- 8.Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276(5319):1699–1702PubMedCrossRefGoogle Scholar
- 25.Waagepetersen HS, Qu H, Sonnewald U, Shimamoto K, Schousboe A (2005) Role of glutamine and neuronal glutamate uptake in glutamate homeostasis and synthesis during vesicular release in cultured glutamatergic neurons. Neurochem Int 47(1–2):92–102. doi: 10.1016/j.neuint.2005.04.012 PubMedCrossRefGoogle Scholar
- 29.Helms HC, Madelung R, Waagepetersen HS, Nielsen CU, Brodin B (2012) In vitro evidence for the brain glutamate efflux hypothesis: brain endothelial cells cocultured with astrocytes display a polarized brain-to-blood transport of glutamate. Glia 60(6):882–893. doi: 10.1002/glia.22321 PubMedCrossRefGoogle Scholar
- 32.Yang J, Kong X, Martins-Santos ME, Aleman G, Chaco E, Liu GE, Wu SY, Samols D, Hakimi P, Chiang CM, Hanson RW (2009) Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha. J Biol Chem 284(40):27042–27053. doi: 10.1074/jbc.M109.047340 PubMedCrossRefGoogle Scholar
- 42.McKenna MC, Stevenson JH, Huang X, Hopkins IB (2000) Differential distribution of the enzymes glutamate dehydrogenase and aspartate aminotransferase in cortical synaptic mitochondria contributes to metabolic compartmentation in cortical synaptic terminals. Neurochem Int 37(2–3):229–241PubMedCrossRefGoogle Scholar
- 51.Mangia S, Tkac I, Gruetter R, Van de Moortele PF, Maraviglia B, Ugurbil K (2007) Sustained neuronal activation raises oxidative metabolism to a new steady-state level: evidence from 1H NMR spectroscopy in the human visual cortex. J Cereb Blood Flow Metab 27(5):1055–1063. doi: 10.1038/sj.jcbfm.9600401 PubMedGoogle Scholar
- 60.DiNuzzo M, Mangia S, Maraviglia B, Giove F (2012) The role of astrocytic glycogen in supporting neuronal activity. Neurochem Res. doi: 10.1007/s11064-012-0802-5.
- 61.DiNuzzo M, Giove F (2012) Activity-dependent energy budget for neocortical signaling: Effect of short-term synaptic plasticity on the energy expended by spiking and synaptic activity. J Neurosci Res. doi: 10.1002/jnr.23098.